Arati V Kulkarni, Raghavendra Kini, Prasanna Kumar Rao, Gowri P Bhandarkar, Roopashri Rajesh Kashyap

İlaca bağlı diş eti büyümesi: diş hekiminin ikilemi

Dişeti büyümesi düzenli diş pratiğinde rutin bir bulgudur. Pek çok etiyolojik etkene sahip olmasına rağmen, sistemik problemleri tedavi etmek için uygulanan ilaçlara bağlı genişleme, dikkat edilmesi gereken önemli bir konudur. İlaç kaynaklı dişeti aşırı büyümesi sıklıkla anti hipertansifler, antikonvülzanlar ve immünsüpresanlar ile ilişkilidir. Gingival büyüme geliştikçe, normal ağız hijyeni pratiğini etkiler ve çiğneme fonksiyonlarına müdahale edebilir. Bu yavaş yavaş bir ağrı kaynağı haline gelir ve durum genellikle bozulmaya yol açar. Bu istenmeyen etkiyi geliştiren hasta grubunda, dişeti değişimlerinin boyut ve şiddetinde değişkenlik olduğu görülmektedir. Olası risk faktörlerini tanımlamak ve araştırmak ve tedavi planı ile ilişkilendirmek ideal görünmektedir. Burada, beş yıldan beri nifedipin tedavsi almaktayken ilaca bağlı gingival büyümesi olan 33 yaşında bir kadın hasta sunulmuş ve tedavisi tartışılmıştır.

Drug induced gingival enlargement: dentist’s dilemma

Gingival enlargement is a routine finding in regular dental practice. Though it has many etiological factors, enlargement due to drugs which are administered to treat the systemic problems is of major concern which needs attention. Drug-induced gingival overgrowth is frequently associated with anti hypertensives, anticonvulsants and immunosuppressants. As gingival enlargement develops, it affects the normal oral hygiene practice and may interfere with masticatory functions. It gradually becomes a source of pain and the condition often leads to disfiguration. Within the group of patients that develop this unwanted effect, there appears to be variability in the extent and severity of the gingival changes. It would seem ideal to identify and explore possible risk factors and relate them with the treatment plan. Here, we present a case of a 33 year old female patient on nifedipine since five years with drug induced gingival enlargement and its management

Keywords:

Gingival enlargement, calcium channel blockers, nifedipine,

PDF

___

1. Vekaria A, Sheth T, Shah S, Shah M. Nifedipine induced gingival enlargement-A systematic treatment approach. J Adv Oral Res. 2015;6:49-52.
2. Harel-Raviv M, Eckler M, Lalani K, Raviv E, Gornitsky M. Nifedipine induced gingival hyperplasia. A comprehensive review and analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:715-22.
3. Tavassoli S, Yamalik N, Caglayan F, Caglayan G, Eratalay K. The clinical effects of nifedipine on periodontal status. J Periodontology. 1998;69:108-12.
4. Lumerman H, Reuben S, Freedman PD. Gingival hyperplasia associated with nifedipine therapy. Oral Surg Oral Med Oral Pathol. 1984;57:620-1.
5. Amit B, Shalu BV. Gingival enlargement induced by anticonvulsants, immunosupprassants and calcium channel blockers: a review. International Research Journal of Pharmacy. 2012;3:116-9.
6. Hancock RH, Swan PH. Nifedipine- induced gingival over growth - teport of a case treated by controlling plaque. J Clin Periodontol. 1992;19:12–4.
7. Lu HK, Chou HP, Li CL, Wang MY, Wang LF. Stimulation of cells derived from nifedipine-induced gingival overgrowth with porphyromonas gingivalis lipopolysaccharide, and interleukin-1β J Dent Res. 2007;86:1100–4.
8. Sunil PM, Nalluswami JS, Sanghar SJ, Joseph I. Nifedipine-induced gingival enlargement: correlation with dose and oral hygiene. Journal of Pharmacy & Bioallied Sciences. 2012;4:191-3.
9. Livada R, Shiloah J. Calcium channel blocker-induced gingival enlargement J Hum Hypertens. 2014:28:10-4.
10. Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced gingival hyperplasia: Phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc. 1987;114:56-60.
11. .Marshall RI, Bartold PM. A clinical review of drug induced gingival overgrowth. Aust Dent J. 1999;44:219-32.
12. Newman MG, Takei H, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology, 10th edition. St Louis, Saunders, Elsevier, 2006.
13. Dongari-Bagtzoglou A; Research, Science and Therapy Committee, American Academy of Periodontology. Drug-associated gingival enlargement. J Periodontol. 2004;75:1424-31..
14. Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA .The management of drug-induced gingival overgrowth. J Clin Periodontol.. 2006;33:434-9.
15. Dhale R.P ,Phadnaik M B. Conservative management of amlodipine influenced gingival enlargement, J Indian Soc Periodon. 2009;13:41–2
16. Srivastava AK, Kundu D, Bandyopadhyay P, Pal AK. Management of amlodipine induced gingival enlargement: series of three cases J Indian Soc Periodontol. 2010;14:279–81.
17. Sam.G, Sebastian S C. Nonsurgical management of nifedipine induced gingival overgrowth. Case Rep Dent. 2014;741402, 4.
18. Bharti V, Bansal C. Drug-induced gingival overgrowth: the nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013;17:182-7.